Skip to Content

ENA 50 (Idhifa 50 mg)

Generic Name: enasidenib

Pill with imprint ENA 50 is Yellow, Elliptical / Oval and has been identified as Idhifa 50 mg. It is supplied by Celgene Corporation.

Idhifa is used in the treatment of acute myeloid leukemia and belongs to the drug class miscellaneous antineoplastics. Idhifa 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ENA 50

Idhifa 50 mg ENA 50

Idhifa

Generic Name
enasidenib
Imprint
ENA 50
Strength
50 mg
Color
Yellow
Size
12.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Miscellaneous antineoplastics
CSA Schedule
Not a controlled drug
Labeler / Supplier
Celgene Corporation
National Drug Code (NDC)
59572-0705
Inactive Ingredients
microcrystalline cellulose, sodium starch glycolate type A potato, sodium lauryl sulfate, hypromellose acetate succinate 06081224 (3 mm2/s), silicon dioxide, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol, magnesium silicate, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "ENA 50"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.